Speaking at IAS 2008, Dr Andrew Carr from St Vincent’s Hospital Sydney said that the increasing numbers of people with HIV developing non-AIDS illnesses (such as cardiovascular disease or renal problems) has prompted discussions amongst physicians as to whether the guidelines for starting treatment (currently at 350 T-cells) might be better changed to between 350 and 500 T-cells.
“We don’t currently know what makes these diseases more of a problem in people with HIV,” said Dr Carr. “Of course there are the usual co-factors like smoking for cardiovascular disease but even accounting for these, the rates on non- AIDS illnesses are significant. The SMART Study to start in early 2009 could provide some of the answers. It may be related to the inflammation caused by HIV but at this stage we can’t be certain.”
www.poz.com
This article was first published in September 2008.
While the content of this article was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.
More stories from this issue.
This article contains medical information. NAPWA makes every reasonable effort to ensure the information on this website is accurate, reliable and up-to-date, including obtaining technical reviews by medically-qualified reviewers, however the authors of information on this website are not qualified to give medical advice, except where explicitly stated.
The content of this website is intended to support, not replace, the relationship between people living with HIV/AIDS and their medical advisers, and is not intended as a substitute for medical advice.
Posted online: 24 September 2008.
Last updated: 24 September 2008.
More stories about: